story of the week
Mechanisms of Enhanced Renal and Hepatic Erythropoietin Synthesis by SGLT2 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitors
Eur Heart J 2023 Apr 22;[EPub Ahead of Print], M PackerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.